Nature vs. Nurture: Defining the Effects of Mesenchymal Stromal Cell Isolation and Culture Conditions on Resiliency to Palmitate Challenge
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nature vs. Nurture: Defining the Effects of Mesenchymal Stromal Cell Isolation and Culture Conditions on Resiliency to Palmitate Challenge
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-10
DOI
10.3389/fimmu.2019.01080
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines
- (2019) Guido Moll et al. TRENDS IN MOLECULAR MEDICINE
- Inflammation-induced glycolytic switch controls suppressivity of mesenchymal stem cells via STAT1 glycosylation
- (2019) R. Jitschin et al. LEUKEMIA
- Manufacturing of primed mesenchymal stromal cells for therapy
- (2019) James Q. Yin et al. Nature Biomedical Engineering
- Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges
- (2018) Valentin Jossen et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Manufacturing mesenchymal stromal cells for the treatment of graft-versus-host disease: a survey amongst centers affiliated to the European Group of Blood and Marrow Transplantation
- (2018) Cristina Trento et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Large-scale Production of Stem Cells Utilizing Microcarriers: A Biomaterials Engineering Perspective from Academic Research to Commercialized Products
- (2018) Hossein Tavassoli et al. BIOMATERIALS
- Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
- (2018) Jacques Galipeau et al. Cell Stem Cell
- The redox requirements of proliferating mammalian cells
- (2018) Aaron M. Hosios et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate
- (2018) Lauren Boland et al. MOLECULAR THERAPY
- Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use
- (2018) Katarzyna Kornicka et al. Stem Cell Reviews and Reports
- Global phenotypic characterisation of human platelet lysate expanded MSCs by high-throughput flow cytometry
- (2018) Monica Reis et al. Scientific Reports
- Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience
- (2018) Valentina Becherucci et al. Stem Cell Research & Therapy
- Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use
- (2018) Katarzyna Kornicka et al. Stem Cell Reviews and Reports
- RNA-seq reveals diverse effects of substrate stiffness on mesenchymal stem cells
- (2018) Max Darnell et al. BIOMATERIALS
- PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients
- (2018) Vivian Capilla-González et al. MOLECULAR THERAPY
- Functional Profiling of Chondrogenically Induced Multipotent Stromal Cell Aggregates Reveals Transcriptomic and Emergent Morphological Phenotypes Predictive of Differentiation Capacity
- (2018) Johnny Lam et al. Stem Cells Translational Medicine
- Bioprocessing of Mesenchymal Stem Cells and Their Derivatives: Toward Cell-Free Therapeutics
- (2018) Jolene Phelps et al. Stem Cells International
- Morphological profiling using machine learning reveals emergent subpopulations of interferon-γ–stimulated mesenchymal stromal cells that predict immunosuppression
- (2018) ROSS A. MARKLEIN et al. CYTOTHERAPY
- Morphological features of IFN-γ–stimulated mesenchymal stromal cells predict overall immunosuppressive capacity
- (2017) Matthew W. Klinker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Platelet Lysate versus Fetal Calf Serum: These Supplements Do Not Select for Different Mesenchymal Stromal Cells
- (2017) Eduardo Fernandez-Rebollo et al. Scientific Reports
- Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction
- (2017) Arantxa Blázquez-Prunera et al. Stem Cell Research & Therapy
- A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis
- (2017) Özge Kizilay Mancini et al. Stem Cells Translational Medicine
- Mitochondrial Oxidative Stress Reduces the Immunopotency of Mesenchymal Stromal Cells in Adults With Coronary Artery Disease
- (2017) Ozge Kizilay Mancini et al. CIRCULATION RESEARCH
- Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers
- (2017) Shutong Liu et al. Scientific Reports
- Senescence-Associated MCP-1 Secretion Is Dependent on a Decline in BMI1 in Human Mesenchymal Stromal Cells
- (2016) Hye Jin Jin et al. ANTIOXIDANTS & REDOX SIGNALING
- Characterization of human mesenchymal stem cells from multiple donors and the implications for large scale bioprocess development
- (2016) Thomas R.J. Heathman et al. BIOCHEMICAL ENGINEERING JOURNAL
- Scalability and process transfer of mesenchymal stromal cell production from monolayer to microcarrier culture using human platelet lysate
- (2016) Thomas R.J. Heathman et al. CYTOTHERAPY
- Trends in Obesity Among Adults in the United States, 2005 to 2014
- (2016) Katherine M. Flegal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quality cell therapy manufacturing by design
- (2016) Yonatan Y Lipsitz et al. NATURE BIOTECHNOLOGY
- MicroRNA-21 preserves the fibrotic mechanical memory of mesenchymal stem cells
- (2016) Chen Xi Li et al. NATURE MATERIALS
- Obesity and Type 2 Diabetes Alters the Immune Properties of Human Adipose Derived Stem Cells
- (2016) Carolina Serena et al. STEM CELLS
- Human Adipose Stromal/Stem Cells from Obese Donors Show Reduced Efficacy in Halting Disease Progression in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
- (2016) Amy L. Strong et al. STEM CELLS
- Obesity Determines the Immunophenotypic Profile and Functional Characteristics of Human Mesenchymal Stem Cells From Adipose Tissue
- (2016) Gisela Pachón-Peña et al. Stem Cells Translational Medicine
- No Identical “Mesenchymal Stem Cells” at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels
- (2016) Benedetto Sacchetti et al. Stem Cell Reports
- Proteome analysis of human amniotic mesenchymal stem cells (hA-MSCs) reveals impaired antioxidant ability, cytoskeleton and metabolic functionality in maternal obesity
- (2016) Valentina Capobianco et al. Scientific Reports
- Increasing efficiency of human mesenchymal stromal cell culture by optimization of microcarrier concentration and design of medium feed
- (2015) Allen Kuan-Liang Chen et al. CYTOTHERAPY
- Persistent DNA damage-induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells
- (2015) Valentina Minieri et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cell cycle staging of individual cells by fluorescence microscopy
- (2015) Vassilis Roukos et al. Nature Protocols
- The translation of cell-based therapies: clinical landscape and manufacturing challenges
- (2015) Thomas RJ Heathman et al. Regenerative Medicine
- Changes in autophagy, proteasome activity and metabolism to determine a specific signature for acute and chronic senescent mesenchymal stromal cells
- (2015) Stefania Capasso et al. Oncotarget
- Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media
- (2015) Angelos Oikonomopoulos et al. Scientific Reports
- Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
- (2015) Ozge Kizilay Mancini et al. Stem Cell Research & Therapy
- Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review
- (2015) Krishna M. Panchalingam et al. Stem Cell Research & Therapy
- In Vivo Therapeutic Potential of Mesenchymal Stromal Cells Depends on the Source and the Isolation Procedure
- (2015) Francesca Bortolotti et al. Stem Cell Reports
- Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study
- (2014) Wenjie Ma et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells
- (2014) Francisco dos Santos et al. BIOTECHNOLOGY AND BIOENGINEERING
- MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
- (2014) Michael Mendicino et al. Cell Stem Cell
- Obesity-driven disruption of haematopoiesis and the bone marrow niche
- (2014) Benjamin J. Adler et al. Nature Reviews Endocrinology
- TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo
- (2014) Ryang Hwa Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids
- (2014) James A. Ankrum et al. Scientific Reports
- Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells
- (2013) Georg Siegel et al. BMC Medicine
- Adipose Mesenchymal Stromal Cells Isolated From Type 2 Diabetic Patients Display Reduced Fibrinolytic Activity
- (2013) L. Acosta et al. DIABETES
- TSG-6 Produced by hMSCs Delays the Onset of Autoimmune Diabetes by Suppressing Th1 Development and Enhancing Tolerogenicity
- (2013) D. J. Kota et al. DIABETES
- Clinical-Grade Mesenchymal Stromal Cells Produced Under Various Good Manufacturing Practice Processes Differ in Their Immunomodulatory Properties: Standardization of Immune Quality Controls
- (2013) Cedric Menard et al. STEM CELLS AND DEVELOPMENT
- Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model
- (2013) Brittni A. Scruggs et al. Stem Cells Translational Medicine
- Increase of Palmitic Acid Concentration Impairs Endothelial Progenitor Cell and Bone Marrow-Derived Progenitor Cell Bioavailability: Role of the STAT5/PPAR Transcriptional Complex
- (2012) A. Trombetta et al. DIABETES
- Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC
- (2011) Ralf Hass et al. Cell Communication and Signaling
- Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation
- (2011) Moïra François et al. MOLECULAR THERAPY
- Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses
- (2011) Guido Moll et al. PLoS One
- Platelet Lysate Consisting of a Natural Repair Proteome Supports Human Mesenchymal Stem Cell Proliferation and Chromosomal Stability
- (2010) Ruben Crespo-Diaz et al. CELL TRANSPLANTATION
- Mesenchymal stem cell therapy: Two steps forward, one step back
- (2010) James Ankrum et al. TRENDS IN MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started